GSK3B and Alzheimer disease: Moreover, GSK-3β is involved in the accumulation of α-synuclein aggregates, oxidative stress and mitochondrial dysfunction, which make this kinase an attractive therapeutic target for neurodegenerative disorders, such as AD or PD [19].